跳转到主要内容
搜索

2025 年 1 月 29 日

Radnor, Pa. — January 29th, 2025 — Certara, Inc. (纳斯达克股票代码:CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2024 after the market close on Wednesday, February 26th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.

Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.

Certara also announced that company management will participate in the following investor conferences:

  • Leerink Partners Global Healthcare Conference
    Date and Time: Tuesday, March 11th at 1:00PM ET
  • Barclays 27th Annual Global Healthcare Conference
    Date and Time: Wednesday, March 12th at 11:30AM ET

Live and archived webcasts of these events will be available on the “Investors” section of the Certara website at https://ir.certara.com/.

关于Certara

Certara 致力于通过生物模拟软件、技术和服务加速药物研发,改变传统的药物研发方式。其客户包括超 2,400 家生物制药公司、学术机构和来自 66 个国家的监管机构。Learn more at www.certara.com.

Investor Relations contact:

David Deuchler
Gilmartin Group
{1}

媒体联系人:

Alyssa Horowit
{1}

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software